Mosquito repellent for malaria prevention in children
Part of Infections clinical trials.
This trial tests a long-acting mosquito repellent that could help prevent malaria. It is for children living in the study area, and simply involves letting us know if your child is home for a visit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 1 and 15 years old
- Your child must have been living in this area for at least 4 months
- Your child must be home the night before the survey visit
- A parent or guardian must agree to let the child take part
- Children 12 or older must also agree to take part themselves
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if giving schoolchildren malaria-prevention medicine at certain times can lower malaria in the community. It might help protect your child and others from getting sick.
This study tests a new long-acting injection to prevent malaria. It checks safety and how the body handles the drug in healthy adults and adolescents in Rwanda.
This study looks at how malaria spreads in Mozambique by testing children and pregnant women with fever. If you or your child may have malaria, participating could help researchers understand and fight the disease better.
This study tests different schedules of a malaria prevention medicine to see which works best for improving school attendance, learning, and executive function in children aged 6 to 10 in Siaya County, Kenya.
This study tests a device called the Guardian Spatial Emanator, which may help prevent malaria. It is being added to an existing program that distributes antibiotics to reduce infections in high-malaria areas.
This study tests a genetically modified malaria parasite that is intentionally given to healthy volunteers through a mosquito bite. The goal is to see if it is safe and to learn how the immune system responds, which could help develop a malaria vaccine.
Hear when a new Malaria Transmission trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.